8/27/25 16:10 | 8/25/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Nusse Roeland | MN | D | | 2 | M.d | 1,333 | 39.10 | 0 | 34 | 325 | 45 | D | | | | | | | | | | | | | | |
8/27/25 16:10 | 8/25/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Nusse Roeland | MN | D | | 2 | S.d | -1,333 | 39.10 | 0 | -34 | | 45 | D | | | | | | | | | | | | | | |
8/27/25 16:09 | 8/25/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Baumgartner Robert V | MN | D | | 2 | M.d | 1,330 | 39.03 | 0 | 34 | 316 | 45 | D | | | | | | | | | | | | | | |
8/27/25 16:09 | 8/25/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Baumgartner Robert V | MN | D | | 2 | S.d | -1,330 | 39.03 | 0 | -34 | | 45 | D | | | | | | | | | | | | | | |
8/19/25 17:38 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | 2 | M.d | 7,475 | 43.30 | 0 | 173 | | 130 | D | | | | | | | | | | | | | | |
8/19/25 17:29 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Herr Amy E. | MN | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 10 | 3 | I | | | | | | | | | | | | | | |
8/19/25 17:28 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Kelderman Kim | MN | DO | CEO | 3 | M.d | 3,737 | 40.25 | 0 | 93 | | 51 | D | | | | | | | | | | | | | | |
8/19/25 17:28 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Bohnen Shane | MN | O | SVP - GC | 1 | M.d | 0 | 0.00 | 0 | 2 | 64 | 4 | D | | | | | | | | | | | | | | |
8/19/25 17:28 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | McManus Matthew | MN | O | P - Diag | 1 | M.d | 0 | 0.00 | 0 | 3 | 126 | 5 | D | | | | | | | | | | | | | | |
8/19/25 17:27 | 8/15/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Geist William | MN | O | P,Protei | 1 | M.d | 0 | 0.00 | 0 | 3 | 21 | 15 | D | | | | | | | | | | | | | | |
8/11/25 19:06 | 8/7/25 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | MN | D | | 1 | M.d | 110 | 21.84 | 0 | 5 | 8 | 65 | D | | | | | | | | | | | | | | |